BSE
BSE Ltd operates India's oldest stock exchange plus clearing, data and mutual-fund distribution platforms, earning fees on cash and derivatives trading, listings and IPOs.
- P/E ~50x
- Profit +45% YoY (Q2FY27)
- No promoter - LIC largest holder
- F&O expiry-rule risk
- 13.5% off peak
Updated on 8 Nov 2026 · Data as of 6 Nov 2026
Get this report as a PDF free, straight to your inbox.
Snapshot
- Share price
- ₹3,800.00
- 6 Nov 2026
- 52-week range
- ₹2,449.05 – ₹4,391.73
- All-time peak
- ₹4,391.73
- 26 May 2026 · −13.5% from peak
- Dividend yield
- 0.26%
- Price history since
- 2017
- About 9 years of prices
What's happening
Q2 FY27 results (quarter ended Sep 2026, announced ~Nov 4, 2026): consolidated revenue rose 34% YoY to ₹1,433 crore and net profit rose 45% YoY to ₹809 crore, helped by a record primary market (71 mainboard IPOs raising over ₹84,000 crore in H1FY27) and record cash-equity trading volumes. Separately, BSE has invited applications (deadline Nov 19, 2026) for a new MD & CEO, as incumbent Sundararaman Ramamurthy's term runs to June 2027. In late September, Goldman Sachs and BNP Paribas together sold a 1.67% stake worth about ₹2,186 crore via bulk deal, briefly pressuring the stock.
In plain terms
BSE makes money whenever someone trades shares, buys a mutual fund, or lists a new company on the exchange - so its profit tracks how busy the markets are, not steady repeat sales. The last quarter was strong because IPOs and trading volumes were unusually high, which is a cyclical tailwind rather than something guaranteed to repeat. The tension: SEBI recently forced exchanges to fix their derivatives expiry days, and some analysts think this could cost BSE market share in its most profitable segment. The stock already prices in a lot of future growth, so it has little room for that risk to go wrong.
Quarters
Net profit: ₹597cr (Q3FY26, Dec'25) → ₹795cr (Q4FY26, Mar'26) → ₹873cr (Q1FY27, Jun'26) → ₹809cr (Q2FY27, Sep'26). Revenue in the latest quarter was ₹1,433cr. Note profit actually fell about 7% sequentially from Q1 to Q2 even though it was up 45% year-on-year - the YoY comparison looks strong partly because last year's base was weaker. Management flagged EBITDA margin expansion to roughly 67% from 64% a year ago, and cited record IPO fundraising and cash-equity average daily traded value (₹10,494cr) as drivers. No non-comparability flags found in the figures checked.
Performance
Heads-up on splits: BSE has split its shares or issued bonus shares before (most recently 3-for-1 on 23 May 2025 and 3-for-1 on 21 Mar 2022). A sudden price drop around a split date is usually just the price adjusting for the extra shares, not a crash.
Share price
+55.2% over 1 year
Returns by period
| Period | BSE | Nifty 50 | MCX |
|---|---|---|---|
| 3 months | +9.9% | +1.9% | +34.1% |
| 1 year | +55.2% | −1.9% | +91.2% |
| 3 years | +471.9% | +29.0% | +577.5% |
| 5 years | +2464.8% | +38.5% | +896.5% |
₹100 invested on 8 Nov 2021 became…
- BSE₹2565
- Nifty 50₹139
- MCX₹996
The stock is up 55% over 1 year, 472% over 3 years and about 2,465% over 5 years, versus a roughly flat-to-down Nifty over 1 year and modest 29-39% gains over 3-5 years - a huge outperformance. Two 3-for-1 stock splits (March 2022 and May 2025) explain why the nominal price today (₹3,800) looks modest next to the exchange's history; the returns supplied are already split-adjusted, so there's no artificial inflation or deflation here. The current price is 13.5% below the May 2026 peak of ₹4,391.73 - a normal pullback within an uptrend, not a crash. Against peer MCX, BSE has lagged over 1 year (+55% vs +91%) and 3 years (+472% vs +577%) but has outperformed over 5 years (+2,465% vs +896%).
Dividend
Paid in the last 12 months
₹10.00 per share
Dividend yield
0.26%
Dividend yield is the last 12 months of dividends divided by today's share price. A 0.3% yield means every ₹100 of BSE shares paid about ₹0.3 in dividends over the past year. Past payouts can change.
Recent dividends
| Date | Per share |
|---|---|
| 10 Jul 2026 | ₹10.00 |
| 14 May 2025 | ₹7.67 |
| 14 Jun 2024 | ₹5.00 |
| 4 Aug 2023 | ₹4.00 |
| 23 Jun 2022 | ₹4.50 |
| 5 Aug 2021 | ₹2.33 |
| 22 Jul 2020 | ₹1.89 |
| 27 Jun 2019 | ₹2.78 |
Valuation
BSE trades at roughly 50x trailing earnings and about 19.5x book value - a rich multiple even after profit growth. Why it's expensive: near-zero debt, ~60% ROCE, and genuine operating leverage from record IPO and trading activity, not an accounting illusion. Whether it's cheap is a separate question - Goldman Sachs, an outlier worth naming, holds a Neutral rating with a target near ₹2,430, well below the current ₹3,800, on the view that F&O expiry-rule changes could structurally cap BSE's derivatives market share. The gap between that target and the market price shows real disagreement about how durable this growth is.
Growth
Growth this quarter was both volume-led and margin-led: cash-equity trading volumes hit a record, StAR MF (mutual fund) transactions grew 22% YoY, and EBITDA margin still expanded to about 67% from 64%. That combination is healthier than margin-only growth, but a meaningful chunk of it rides on a record IPO cycle (71 listings raising over ₹84,000 crore in H1FY27) that is cyclical and could cool.
Health
Profits convert readily to cash - BSE collects exchange fees, not receivables from customers buying on credit - and the balance sheet is almost debt-free with ROE near 46% and ROCE near 60%. The real risk here is business/regulatory, not financial: SEBI's move to fix weekly F&O expiry days has prompted Goldman Sachs to estimate a possible 10-15% derivatives volume hit and 5-10% earnings impact, which is the factor that could actually move results, not balance-sheet stress.
Ownership
BSE is a demutualized exchange with no promoter group - its shareholders are entirely institutional and public investors, so the usual pledging checks don't apply. LIC is the single largest shareholder at about 5.6%, with smaller stakes held by Vanguard, ICICI Prudential AMC, Nippon Life AMC and others. No well-known individual 'guru' investor shows up on the disclosed register. In late September 2026, Goldman Sachs and BNP Paribas - institutional holders, not promoters - sold a combined 1.67% stake (about ₹2,186 crore) in a bulk deal, which briefly pressured the stock; this was an exit by foreign institutional sellers, not an insider signal.
The View
The one thing to watch
BSE's monthly F&O premium turnover and derivatives market-share data, plus the next quarterly results (likely early February 2027), will show whether the Thursday-expiry shift actually dents volumes as Goldman Sachs expects, or whether BSE keeps gaining share as it did through 2026.
Strengths
- +Net profit up 45% YoY to ₹809 crore in Q2FY27, driven by a record IPO pipeline (71 listings raising over ₹84,000 crore in H1FY27)
- +ROE near 46% and ROCE near 60% on a balance sheet that is almost debt-free
- +EBITDA margin expanded to roughly 67% from about 64% a year earlier
- +StAR MF mutual-fund platform transactions up 22% YoY to 24.5 crore in the quarter, diversifying revenue beyond pure trading fees
Watchpoints
- !SEBI's mandated shift of weekly F&O expiry to Thursday has Goldman Sachs projecting a possible 10-15% derivatives volume drop and 5-10% earnings hit - the key swing factor for the stock
- !Trading at roughly 50x earnings and 19.5x book value, so any slowdown in the IPO pipeline or loss of derivatives market share would compress the multiple quickly
- !MD & CEO succession search underway (applications close Nov 19, 2026) ahead of the incumbent's June 2027 term end - routine, but a leadership transition to track
- !Profit fell sequentially from ₹873 crore (Q1FY27) to ₹809 crore (Q2FY27) even as the year-on-year comparison stayed strong - worth watching whether this is noise or a turn
How sure are we about the data? · Moderate
Q2FY27 revenue (~₹1,433cr) and net profit (~₹808-809cr, +45% YoY) were cross-checked across Screener.in, Angel One, Multibagg.ai and MarketsMojo and are consistent. P/E (~50x), P/B (~19.5x), ROE (~46%) and ROCE (~60%) confirmed via Screener.in. Shareholding splits vary slightly by aggregator (institutional totals range 43-46% depending on source); Screener's FII ~17.1%/DII ~25.9%/Public ~56.7% was used as the primary cluster, with a conflicting Choice India breakdown set aside as the outlier. LIC's 5.6% stake is sourced from a single secondary report (fa.news/BusinessToday) and could not be independently verified against a primary shareholding filing. Not verified - exact FY26 full-year revenue/profit and any share buyback (a Business Standard 'buyback' topic page exists but no active 2026 buyback was found in searches).
Keep it for later
Get the BSE report as a PDF
The full report, neatly laid out with charts and tables, sent to your inbox. Handy to read offline or share.
Reports are refreshed every quarter, about three days after each company announces its results.
Ticker Tales is not a SEBI-registered investment adviser or research analyst. This report is for learning only and is not investment advice. Data as of 6 Nov 2026.